Dysplastic Nodule, Hepatic

2008 ◽  
pp. 658-658
Keyword(s):  
Dysplastic Nodule

Predictors of Dysplastic Nodule Diagnosis in Patients With Liver Cirrhosis on Unenhanced and Gadobenate Dimeglumine–Enhanced MRI With Dynamic and Hepatobiliary Phase

2013 ◽  
Vol 200 (3) ◽  
pp. 553-562 ◽  
Author(s):  
Emilio Quaia ◽  
Luca De Paoli ◽  
Riccardo Pizzolato ◽  
Roberta Angileri ◽  
Emmanuela Pantano ◽  
...  
Keyword(s):  
Liver Cirrhosis ◽  
Gadobenate Dimeglumine ◽  
Hepatobiliary Phase ◽  
Dysplastic Nodule ◽  
Enhanced Mri

scholarly journals Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma

2012 ◽  
Vol 41 (6) ◽  
pp. 2150-2158 ◽  
Author(s):  
JUN SANG BAE ◽  
SANG JAE NOH ◽  
KYU YUN JANG ◽  
HO SUNG PARK ◽  
MYOUNG JA CHUNG ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Cell Adhesion ◽  
Epithelial Cell ◽  
Adhesion Molecule ◽  
Cell Adhesion Molecule ◽  
Dysplastic Nodule ◽  
Epithelial Cell Adhesion Molecule

scholarly journals MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

2014 ◽  
Vol 2014 ◽  
pp. 1-11 ◽  
Author(s):  
Chao-Hung Hung ◽  
Yi-Chun Chiu ◽  
Chien-Hung Chen ◽  
Tsung-Hui Hu
Keyword(s):  
Hepatocellular Carcinoma ◽  
Tumor Suppressor Genes ◽  
Current Knowledge ◽  
Biological Processes ◽  
Dysplastic Nodule ◽  
Key Factors ◽  
Diagnostic Biomarkers ◽  
Small Noncoding Rnas ◽  
Cancer Pathogenesis ◽  
Multistep Process

Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer, with dismal outcomes and an increasing incidence worldwide. Hepatocarcinogenesis is a multistep process that progresses from chronic hepatitis through cirrhosis and/or dysplastic nodule to HCC. However, the detailed molecular pathogenesis remains unclear. MicroRNAs (miRNAs), small noncoding RNAs that regulate the translation of many genes, have emerged as key factors involved in several biological processes, including development, differentiation, and cell proliferation. Recent studies have uncovered the contribution of miRNAs to the cancer pathogenesis, as they can behave as oncogenes or tumor suppressor genes. In addition, other studies have demonstrated their potential values in the clinical management of HCC patients as some miRNAs may be used as prognostic or diagnostic markers. In this review, we summarize current knowledge about the roles of miRNAs in carcinogenesis and progression of HCC. We also discuss the potential application of miRNAs as diagnostic biomarkers and their potential roles in the intervention of HCC.

Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma

2018 ◽  
Vol 81 ◽  
pp. 37-46 ◽  
Author(s):  
Minho Lee ◽  
Kyung Kim ◽  
Shinn Young Kim ◽  
Seung-Hyun Jung ◽  
Jonghwan Yoon ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Dysplastic Nodule
Sign in / Sign up

Export Citation Format

Share Document